The authors hypothesized that since EPHX2 is involved in the phenotypic transformation of vascular smooth muscle cells that leads to endothelial dysfunction and atherosclerosis, inhibition of its activity might be a potential therapeutic target for ameliorating carotid atherosclerosis and CV disease. This evidence concerns the gene EPHX2 and carotid atherosclerosis.